Georgia Demetriou

Publications

32

Citations

1.2K

h-index

14

Publishing journals

23

Years of publications

17

Active since

2009

References

636

Institutions

4

1. Establishing Requirements for Breast Centers in Low- and Middle-Income Countries: A South African Perspective.
   JCO global oncology, Volume 11, Page e2500168, Year 2025
2. The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer
   The Oncologist, Volume 28, Issue 10, Pages E921-E929, Year 2023
3. Abstract P1-01-03: The Impact of Comorbid HIV infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Breast Cancer Patients
   Cancer Research, Volume 83, Issue 5_Supplement, Pages P1-01-03-P1-01-03, Year 2023
4. Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research
   PLOS Global Public Health, Volume 3, Issue 5, No. e0001970, Page e0001970, Year 2023
5. Validating an instrument for direct patient reporting of distress and chemotherapy-related toxicity among south african cancer patients
   Cancers, Volume 14, Issue 1, No. 95, Pages 95-95, Year 2022
6. Aplastic Anaemia—A South African Context
   Wits Journal of Clinical Medicine, Volume 4, Issue 1, Pages 3-9, Year 2022
7. Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
   European Journal of Cancer, Volume 148, Pages 287-296, Year 2021
8. Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations
   Oncology and Therapy, Volume 9, Issue 1, Pages 225-238, Year 2021
9. Validating an instrument for direct patient reporting of chemotherapy toxicity among South African cancer patients.
   Journal of Clinical Oncology, Volume 39, Issue 28_suppl, Pages 172-172, Year 2021
10. Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial
    UNC Libraries, Year 2020
11. Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network
    JCO Global Oncology, Volume 6, Issue 6, Pages 369-374, Year 2020
12. Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic
    Journal of Assisted Reproduction and Genetics, Volume 37, Issue 7, Pages 1567-1577, Year 2020
13. Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study
    Drug Safety, Volume 43, Issue 3, Pages 233-242, Year 2020
14. Liver transplant for nonresectable colorectal cancer liver metastases in South Africa: A single-center case series
    Experimental and Clinical Transplantation, Volume 18, Issue 7, Pages 842-846, Year 2020
15. Can Endocrine Therapy Reduce the Risk of Breast Cancer in South African Women?
    Wits Journal of Clinical Medicine, Volume 2, Issue 1, Year 2020
16. Abstract OT1-03-04: The importance of central pathology pCR review in an international multicenter neoadjuvant study in HER2 positive early breast cancer - Results of the ABP 980 LILAC trial
    Cancer Research, Volume 80, Issue 4_Supplement, Pages OT1-03-04-OT1-03-04, Year 2020
17. National prospective cohort study of the burden of acute small bowel obstruction
    BJS Open, Volume 3, Issue 3, Pages 354-366, Year 2019
18. Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab
    Targeted Oncology, Volume 14, Issue 6, Pages 647-656, Year 2019
19. Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction
    European Journal of Surgical Oncology, Volume 45, Issue 12, Pages 2319-2324, Year 2019
20. Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study.
    Journal of Clinical Oncology, Volume 37, Issue 15_suppl, Pages 557-557, Year 2019

No publications in the index yet.